PubMed

Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes.

Pfleger C, Mortensen HB, Hansen L, Herder C, Roep BO, Hoey H, Aanstoot HJ, Kocova M, Schloot NC; Hvidøre Study Group on Childhood Diabetes.

Diabetes. 2008 Apr;57(4):929-37. Epub 2008 Feb 25.PMID: 18299313 [PubMed - indexed for MEDLINE]Related articlesFree article

Gender-based dimorphic pattern for interleukin-1 receptor antagonist in type 2 diabetes mellitus.

Ybarra J, Lehmann TN, Golay A, Juge-Aubry CE, Roux-Lombard P, Dayer JM, Meier CA.

Diabetes Metab. 2008 Feb;34(1):75-81. Epub 2008 Feb 1.PMID: 18243027 [PubMed - indexed for MEDLINE]Related articlesFree article

Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetes.

Picardi A, Visalli N, Lauria A, Suraci C, Buzzetti R, Merola MK, Manfrini S, Guglielmi C, Gentilucci UV, Pitocco D, Crinò A, Bizzarri C, Cappa M, Pozzilli P.

Horm Metab Res. 2006 Oct;38(10):668-72.PMID: 17075776 [PubMed - indexed for MEDLINE]Related articles

Elevated circulating adiponectin in type 1 diabetes is associated with long diabetes duration.

Lindström T, Frystyk J, Hedman CA, Flyvbjerg A, Arnqvist HJ.

Clin Endocrinol (Oxf). 2006 Dec;65(6):776-82.PMID: 17121530 [PubMed - indexed for MEDLINE]Related articles

CRP and IL-6 concentrations are associated with poor glycemic control despite preserved beta-cell function during the first year after diagnosis of type 1 diabetes.

Schölin A, Siegbahn A, Lind L, Berne C, Sundkvist G, Björk E, Karlsson FA; Diabetes Incidence Study in Sweden group.

Diabetes Metab Res Rev. 2004 May-Jun;20(3):205-10.PMID: 15133751 [PubMed - indexed for MEDLINE]Related articles

[The role of insulin secretion and insulin resistance in the clinical course of newly diagnosed diabetes mellitus in children]

Szadkowska A, Pietrzak I, Markuszewski L, Bodalski J.

Med Wieku Rozwoj. 2005 Apr-Jun;9(2):223-34. Polish. PMID: 16085963 [PubMed - indexed for MEDLINE]Related articles

[Factors affecting C-peptide level during the first year of type 1 diabetes in children]

Zmysłowska A, Szadkowska A, Andrzejewski W, Wegner O, Wyka K, Młynarski W, Bodalski J.

Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2004;10(2):103-11. Polish. PMID: 15504313 [PubMed - indexed for MEDLINE]Related articlesFree article

New definition for the partial remission period in children and adolescents with type 1 diabetes.

Mortensen HB, Hougaard P, Swift P, Hansen L, Holl RW, Hoey H, Bjoerndalen H, de Beaufort C, Chiarelli F, Danne T, Schoenle EJ, Aman J; Hvidoere Study Group on Childhood Diabetes.

Diabetes Care. 2009 Aug;32(8):1384-90. Epub 2009 May 12.PMID: 19435955 [PubMed - indexed for MEDLINE]Related articlesFree article

Age, sex and ICA influence on beta-cell secretion during the first year after the diagnosis of type 1 diabetes mellitus.

Montaña E, Fernandez-Castañer M, Rosel P, Gomez J, Soler J.

Diabete Metab. 1991 Sep-Oct;17(5):460-8.PMID: 1752347 [PubMed - indexed for MEDLINE]Related articles

Elevated serum levels of adiponectin in children, adolescents and young adults with type 1 diabetes and the impact of age, gender, body mass index and metabolic control: a longitudinal study.

Galler A, Gelbrich G, Kratzsch J, Noack N, Kapellen T, Kiess W.

Eur J Endocrinol. 2007 Oct;157(4):481-9.PMID: 17893263 [PubMed - indexed for MEDLINE]Related articlesFree article

Meal-stimulated glucagon release is associated with postprandial blood glucose level and does not interfere with glycemic control in children and adolescents with new-onset type 1 diabetes.

Pörksen S, Nielsen LB, Kaas A, Kocova M, Chiarelli F, Orskov C, Holst JJ, Ploug KB, Hougaard P, Hansen L, Mortensen HB; Hvidøre Study Group on Childhood Diabetes.

J Clin Endocrinol Metab. 2007 Aug;92(8):2910-6. Epub 2007 May 22.PMID: 17519307 [PubMed - indexed for MEDLINE]Related articlesFree article

Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II study.

Herder C, Brunner EJ, Rathmann W, Strassburger K, Tabák AG, Schloot NC, Witte DR.

Diabetes Care. 2009 Mar;32(3):421-3. Epub 2008 Dec 10.PMID: 19073760 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum IL-1, IL-2, TNFalpha and INFgamma levels of patients with type 1 diabetes mellitus and their siblings.

Ozer G, Teker Z, Cetiner S, Yilmaz M, Topaloglu AK, Onenli-Mungan N, Yüksel B.

J Pediatr Endocrinol Metab. 2003 Feb;16(2):203-10.PMID: 12713258 [PubMed - indexed for MEDLINE]Related articles

Adiponectin has different mechanisms in type 1 and type 2 diabetes with C-peptide link.

Ljubic S, Boras J, Jazbec A, Lovrencic MV, Vidjak V, Erzen DJ, Mileta D.

Clin Invest Med. 2009 Aug 1;32(4):E271-9.PMID: 19640330 [PubMed - indexed for MEDLINE]Related articles

Distinct diagnostic criteria of fulminant type 1 diabetes based on serum C-peptide response and HbA1c levels at onset.

Tanaka S, Endo T, Aida K, Shimura H, Yokomori N, Kaneshige M, Furuya F, Amemiya S, Mochizuki M, Nakanishi K, Kobayashi T.

Diabetes Care. 2004 Aug;27(8):1936-41.PMID: 15277420 [PubMed - indexed for MEDLINE]Related articlesFree article

Is the process of beta-cell destruction in type 1 diabetes at time of diagnosis more extensive in females than in males?

Pozzilli P, Mesturino CA, Crino A, Gross TM, Jeng LM, Visalli N; IMDIAB Group.

Eur J Endocrinol. 2001 Dec;145(6):757-61.PMID: 11720901 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum adiponectin is associated with fasting serum C-peptide in non-obese diabetic patients.

Furuta M, Tamai M, Hanabusa T, Yamamoto Y, Nanjo K, Sanke T.

Diabetes Res Clin Pract. 2006 Jun;72(3):302-7. Epub 2006 Jan 25.PMID: 16442181 [PubMed - indexed for MEDLINE]Related articles

Effect of gliclazide modified release on adiponectin, interleukin-6, and tumor necrosis factor-alpha plasma levels in individuals with type 2 diabetes mellitus.

Drzewoski J, Zurawska-Klis M.

Curr Med Res Opin. 2006 Oct;22(10):1921-6.PMID: 17022850 [PubMed - indexed for MEDLINE]Related articles

The PTPN22 1858T gene variant in type 1 diabetes is associated with reduced residual beta-cell function and worse metabolic control.

Petrone A, Spoletini M, Zampetti S, Capizzi M, Zavarella S, Osborn J, Pozzilli P, Buzzetti R; Immunotherapy Diabetes (IMDIAB) Group.

Diabetes Care. 2008 Jun;31(6):1214-8. Epub 2008 Feb 5.PMID: 18252906 [PubMed - indexed for MEDLINE]Related articlesFree article

The development of microalbuminuria is associated with raised longitudinal adiponectin levels in female but not male adolescent patients with type 1 diabetes.

Amin R, Frystyk J, Ong K, Dalton RN, Flyvbjerg A, Dunger DB.

Diabetologia. 2008 Sep;51(9):1707-13. Epub 2008 Jul 12.PMID: 18622594 [PubMed - indexed for MEDLINE]Related articles